Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Consulting agrmnt

Immunome Inc. (IMNM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Immunome Reports Second Quarter 2023 Financial Results Exton, PA – August 9, 2023 – Immunome, Inc. , a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update. “We believe combining Immunome and Morphimmune’ s technologies represents a major step in our long-term strategy of creating a preeminent oncology therapeutics company,” stated Purnanand Sarma, PhD, President and CEO of Immunome. “Targeted cancer therapies have made great strides in recent years, and the possible synergy between Morphimmune’ s Targeted Effector Platform and Immunome’ s proprietary Discovery Engine presents an..."
05/05/2023 8-K Quarterly results
Docs: "Immunome Reports First Quarter 2023 Financial Results"
03/16/2023 8-K Quarterly results
Docs: "Immunome Reports Fourth Quarter and Full Year 2022 Financial Results EXTON, Pa. – March 16, 2023 - Immunome, Inc. , a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported financial results for the fourth quarter ended December 31, 2022 and provided a corporate update. “Looking back on the past year, the transformative strategic collaboration with AbbVie highlighted the disruptive nature of our discovery platform in finding novel antibody-target pairs based on human memory B-cell response ,” stated Purnanand Sarma, Ph.D., President and CEO of Immunome. “We look forward to continuing to execute on our momentum throughout the upcoming year as we advance our pipeline, includ..."
11/14/2022 8-K Quarterly results
08/05/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/28/2022 8-K Quarterly results
Docs: "Immunome Reports Fourth Quarter and Full Year 2021 Financial Results"
05/12/2021 8-K Quarterly results
Docs: "Immunome Reports First Quarter 2021 Financial Results"
03/25/2021 8-K Quarterly results
11/17/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy